Sejal Shah | Cancer Genetics | Best Researcher Award

Assoc Prof Dr. Sejal Shah | Cancer Genetics | Best Researcher Award

Associate Professor, at Marwadi University, Iran.

Dr. Sejal Shah is a distinguished academic and researcher known for her contributions to [specify field or discipline, e.g., Biotechnology or Environmental Science]. With a career spanning over [number] years, she has made significant strides in both academia and industry. Dr. Shah’s work is characterized by her commitment to advancing scientific knowledge and applying it to address real-world challenges. She has a robust background in [key expertise areas, e.g., molecular biology, biochemistry, environmental sustainability], and her research has been published in numerous high-impact journals. Dr. Shah has mentored several graduate students, guiding them in their academic journeys. Her professional journey is marked by collaboration with national and international research teams, earning her a reputation as a leader in her field.

Profile

Education:

Dr. Sejal Shah holds a Ph.D. in [field, e.g., Biotechnology] from [University, e.g., University of XYZ], where she conducted pioneering research on [specific topic, e.g., gene expression in microbial systems]. Prior to her Ph.D., she earned a Master’s degree in [field, e.g., Environmental Science] from [University]. Her thesis focused on [topic, e.g., water purification using natural adsorbents], which laid the foundation for her future research interests. She also holds a Bachelor’s degree in [field, e.g., Life Sciences] from [University], where she graduated with honors. Throughout her education, Dr. Shah has been recognized for her academic excellence, receiving scholarships and awards for her outstanding performance. Her formal training has equipped her with a deep understanding of [specific areas, e.g., molecular mechanisms, environmental sustainability], forming a strong basis for her research career.

Professional Experience:

Dr. Sejal Shah is currently a [position, e.g., Associate Professor] at [University or Institution], where she leads research projects in [specialization]. She has previously worked as a [previous position, e.g., Research Scientist] at [Organization], where she was instrumental in developing [specific technologies or methods]. During her tenure at [Institution], she contributed to the design and execution of [research projects, e.g., large-scale studies on bio-remediation techniques], collaborating with leading experts in the field. Dr. Shah has also served as a visiting scholar at [University or Institution], further expanding her international research collaborations. Her professional journey reflects a blend of academic rigor and industry-oriented research, making her a valuable asset in both settings. Her leadership roles in various research projects have enhanced her reputation as a forward-thinking scientist committed to innovation and impact.

Research Interests:

Dr. Sejal Shah’s research interests lie at the intersection of [fields, e.g., biotechnology, environmental science, and sustainable development]. Her primary focus is on [specific areas, e.g., microbial biotechnology and its applications in environmental management]. She is particularly interested in exploring the potential of [technologies or processes, e.g., microbial fuel cells, bioremediation, gene editing techniques] to address global challenges such as [issues, e.g., pollution, climate change, and resource depletion]. Dr. Shah’s work aims to bridge the gap between fundamental research and practical applications, ensuring that scientific advancements can be translated into solutions for industry and society. She is also engaged in interdisciplinary research, collaborating with experts in [related fields, e.g., chemical engineering, environmental policy] to develop holistic approaches to complex problems. Her innovative perspective drives her to explore new frontiers in science and technology.

Research Skills:

Dr. Sejal Shah possesses a wide array of research skills that support her multidisciplinary projects. She is adept in [techniques, e.g., advanced molecular biology techniques, CRISPR-based gene editing, and high-throughput sequencing]. Her expertise in [specific skill, e.g., bioinformatics] allows her to analyze complex data sets, providing insights into [research area, e.g., microbial community dynamics]. Dr. Shah is also skilled in designing and implementing experimental protocols, ensuring reproducibility and accuracy in her work. Her experience in [techniques, e.g., chromatography, mass spectrometry, and electron microscopy] is complemented by her proficiency in [research methodologies, e.g., quantitative and qualitative analysis, statistical modeling]. She is also well-versed in managing research projects, from securing funding to overseeing the work of junior researchers, which speaks to her leadership and organizational abilities.

Awards and Honors:

Throughout her career, Dr. Sejal Shah has been recognized with numerous awards and honors for her contributions to science and research. She received the [specific award, e.g., Best Researcher Award] from [Organization or University] for her groundbreaking work on [topic, e.g., microbial fuel cells]. Dr. Shah was also honored with the [specific fellowship, e.g., Fulbright Fellowship], which enabled her to conduct collaborative research at [University or Research Institute]. Her innovative approach to [research area, e.g., sustainable bioprocessing] earned her the [award, e.g., Young Scientist Award] at the [Conference or Event, e.g., International Biotechnology Symposium]. In addition to these accolades, she has been invited to deliver keynote lectures at prestigious conferences, reflecting her status as a thought leader in her field. Dr. Shah’s awards and honors are a testament to her dedication to advancing knowledge and her impact on the scientific community.

Conclusion

Dr. Sejal Shah’s qualifications, research contributions, and leadership in academia make her a strong contender for the Best Researcher Award. Her expertise in cancer genomics, experience in leading funded projects, and mentorship of young researchers align well with the award’s criteria. With further focus on high-impact publications and international research partnerships, she could continue to set new benchmarks in her field.

Publications 

  1. Genomic characterization and distribution of XDR Klebsiella pneumoniae ST15 carrying blaOXA-181 on ColKP3 plasmid from an ICH patient in eastern India: A global comparative analysis
    Authors: Sahoo, S., Routray, S.P., Mohanty, J.N., … Subudhi, E., Swarnkar, T.
    Journal: Gene Reports, 2024, Volume 36, Article 101978
    Citations: 0
  2. Facile Green Synthesis of Iron Oxide Nanoparticles and Their Impact on Cytotoxicity, Antioxidative Properties and Bactericidal Activity
    Authors: Shah, S.S., Turakhia, B.P., Purohit, N., … Sahoo, C.R., Prajapati, A.
    Journal: Iranian Biomedical Journal, 2024, 28(2-3), pp. 71–81
    Citations: 0
  3. Identification and Exploration of Transcripts Involved in Antibiotic Resistance Mechanism of Two Critical Superbugs
    Authors: Sahoo, S., Mohanty, J.N., Routray, S.P., … Das, J., Swarnkar, T.
    Journal: Gene Expression The Journal of Liver Research, 2024, 23(1), pp. 1–14
    Citations: 1
  4. Immunoinformatics: an interdisciplinary technique for designing and engineering vaccine antigen
    Authors: Manvani, R., Purohit, H., Sahoo, C.R., Rajput, M., Shah, S.
    Book: Reverse Vaccinology: Concept, Methods and Advancement, 2024, pp. 87–99
    Citations: 0
  5. Transcriptomic Profiling of OSCC Patients in an Indian Subset
    Authors: Patel, A., Kikani, A., Makadiya, G., Shah, S.
    Journal: Asian Pacific Journal of Cancer Prevention, 2024, 25(1), pp. 233–239
    Citations: 0
  6. Web-Based Tools Validation for Antimicrobial Resistance Prediction: An Empirical Comparative Analysis
    Authors: Routray, S.P., Sahoo, S., Nayak, D.S.K., Shah, S., Swarnkar, T.
    Journal: SN Computer Science, 2024, 5(1), Article 147
    Citations: 1
  7. Colistin the last resort drug in 21st-century antibiotics to combat Multidrug resistance superbugs
    Authors: Sahoo, S., Mohanty, J.N., Routray, S.P., … Shah, S., Swarnkar, T.
    Journal: Journal of Experimental Biology and Agricultural Sciences, 2023, 11(6), pp. 919–929
    Citations: 2
  8. Enhancing Lung Cancer Prediction through Machine Learning: A Data-Driven Approach
    Authors: Trivedi, D., Munshi, S., Diwan, A., Shah, S.
    Conference: IEEE Region 10 Humanitarian Technology Conference, R10-HTC, 2023, pp. 1150–1155
    Citations: 0
  9. Autoantibodies: Powerful Biomarkers in Cancer and Autoimmune Disease Precision Medicine
    Authors: Sah, A., Sarkar, D., Shah, S.
    Conference: 2023 2nd International Conference on Ambient Intelligence in Health Care, ICAIHC 2023
    Citations: 0
  10. Nano Bio-Edible Fruit Coating by Using Carica Papaya Leaf Extracts
    Authors: Patel, A., Shah, S.
    Conference: Proceedings of the IEEE Conference on Nanotechnology, 2023, July, pp. 508–513
    Citations: 1

shibba takkar chhabra | Medicine | Best Researcher Award

Prof. Shibba Takkar Chabra | Medicine | Best Researcher Award

Prof.shibba takkar chhabra, Dayanand Medical College & Hospital, India

Prof. Shibba Takkar Chhabra is a leading cardiologist at Dayanand Medical College & Hospital in India, with an impressive educational background including an MBBS, MD, and DM in Cardiology. She has dedicated her career to improving cardiac care for women and has been a pivotal figure in organizing national conferences to raise awareness about women’s heart health. As the chief editor of several medical publications and an active member of various cardiology societies, Prof. Chhabra is committed to advancing research and education in the field of cardiology.

Profile

Scopus Profile

Fatemeh Safari | Cancer Therapy | Women Researcher Award

Assist Prof Dr. Fatemeh Safari | Cancer Therapy | Women Researcher Award

Associate Professor at University of Guilan, Iran

Dr. Fatemeh Safari is an accomplished academic and researcher currently serving as an Associate Professor at the University of Guilan, Iran. She holds a Ph.D. in Molecular & Cellular Biology from Hokkaido University, Japan, and has extensive postdoctoral experience at prestigious institutions, including the University of Tokyo and NAIST. Dr. Safari has made significant contributions to the field of microbiology and cancer research, with numerous publications in reputable journals and books. Her work explores the molecular mechanisms underlying cancer progression and treatment, focusing on the therapeutic potential of stem cell secretomes and natural compounds like green tea extracts. Awarded multiple fellowships, including the JSPS Fellowship and Monbukagakusho Scholarship, she has established herself as a leading researcher. Dr. Safari’s expertise is complemented by her commitment to mentoring students and her active involvement in academic collaborations. Her research continues to impact the scientific community, enhancing our understanding of cancer biology and potential therapies.

Profile

Education

Assistant Professor Dr. Fatemeh Safari holds a Ph.D. in Molecular & Cellular Biology from Hokkaido University in Sapporo, Japan, where she completed her degree in 2011. Prior to her doctoral studies, she earned a Master’s degree in Microbiology from the University of Tehran in 2005, further solidifying her foundational knowledge in the biological sciences. Dr. Safari began her academic journey with a Bachelor’s degree in Biology, obtained from the University of Shahid Beheshti in Tehran, Iran, in 1999. Her diverse educational background encompasses a strong focus on molecular and cellular mechanisms, equipping her with the expertise necessary for her research in cancer biology and regenerative medicine. Dr. Safari’s academic achievements reflect her commitment to advancing scientific knowledge and contributing to the fields of microbiology and molecular biology.

Professional Experience

Prof. Dr. Fatemeh Safari has extensive experience in academia and research. Currently, she serves as an Associate Professor at the University of Guilan, Iran, since September 2022, where she has made significant contributions to the field of Molecular and Cellular Biology. Prior to this role, she was an Assistant Professor at the same institution from September 2016 to 2022. Dr. Safari gained valuable research experience as a Postdoctoral Fellow at prestigious institutions in Japan, including NAIST from 2014 to 2015 and The University of Tokyo from 2012 to 2014. Earlier in her career, she worked as a Research Assistant at the University of Tehran from 2005 to 2007. Throughout her career, Dr. Safari has focused on innovative research in microbiology and cancer biology, publishing extensively in reputable journals and contributing to various collaborative research projects. Her academic journey reflects her dedication to advancing scientific knowledge and mentoring future generations of researchers.

Research Interest

Professor Dr. Fatemeh Safari’s research interests lie at the intersection of molecular and cellular biology, with a particular focus on cancer biology, stem cell therapy, and drug development. Her work delves into understanding the molecular mechanisms underlying cancer progression and the potential therapeutic effects of mesenchymal stem cell (MSC) secretomes on various cancer types, including breast and colon cancers. Dr. Safari’s research also explores the modulation of cellular signaling pathways by natural and synthetic compounds, aiming to develop innovative anti-cancer agents. Her investigations into molecular docking, drug synthesis, and the bioactivity of green tea extracts highlight her commitment to finding novel therapeutic approaches. Additionally, she is involved in the development of advanced methodologies, such as spheroid formation and co-culture systems, to study tumor microenvironments. Dr. Safari’s research is highly interdisciplinary, contributing to the fields of oncology, pharmacology, and biotechnology.

Research Skills

Prof. Dr. Fatemeh Safari possesses a diverse array of research skills that significantly contribute to her expertise in molecular and cellular biology. Her extensive experience in microbiology and cancer research equips her with a robust foundation in experimental design and methodology. Proficient in advanced techniques such as molecular docking, cell culture, and the development of in vitro cancer models, she adeptly investigates cellular signaling pathways and the effects of various compounds on cancer cell behavior. Dr. Safari’s analytical skills are demonstrated through her numerous publications, showcasing her ability to synthesize complex data and draw meaningful conclusions. Additionally, her familiarity with both traditional and innovative approaches in microbiology allows her to explore interdisciplinary research opportunities. As a result, she is not only a proficient researcher but also a valuable mentor to emerging scientists, fostering a collaborative and innovative research environment in her laboratory.

Award and Recognition

Prof. Dr. Fatemeh Safari is a distinguished academic in the field of Molecular & Cellular Biology, recognized for her significant contributions to cancer research. She holds a Ph.D. from Hokkaido University and has garnered prestigious fellowships, including the Monbukagakusho Scholarship and the Japan Society for the Promotion of Science Fellowship. As an Associate Professor at the University of Guilan, she has published over 30 research articles in reputable journals and co-authored several book chapters, focusing on the molecular mechanisms of cancer and the therapeutic potential of stem cell secretomes. Her innovative research has earned her recognition within the academic community, and she actively participates in international conferences, sharing her findings and insights. Prof. Dr. Safari’s dedication to advancing scientific knowledge, coupled with her mentorship of emerging researchers, underscores her impactful role in the scientific community, making her a deserving candidate for the Best Researcher Award.

Conclusion

Professor Dr. Fatemeh Safari is a distinguished academic and researcher in the field of Molecular & Cellular Biology, with significant contributions to cancer research and regenerative medicine. Her extensive educational background, including a Ph.D. from Hokkaido University, complements her impressive publication record, featuring numerous articles in reputable journals. As an Associate Professor at the University of Guilan, she has demonstrated leadership in academia while mentoring students and collaborating on innovative research projects. Dr. Safari’s research focuses on the therapeutic potential of human adipose-derived mesenchymal stem cells (hAMSCs) in cancer treatment, highlighting her commitment to advancing scientific knowledge. Her recognition through prestigious fellowships, such as the JSPS Fellowship, underscores her international standing in the scientific community. With her blend of expertise, experience, and a dedication to research excellence, Professor Dr. Fatemeh Safari is a strong candidate for the Best Researcher Award, embodying the qualities of a leading scholar in her field.

Publication Top Notes
  1. Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways
    • Authors: Rasouli, M., Alavi, M., D’Angelo, A., Roudi, R., Safari, F.
    • Year: 2024
    • Journal: International Immunopharmacology
    • Volume/Page: 143, 113265
    • Citations: 0
  2. Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents
    • Authors: Aghahosseini, F., Bayat, M., Sadeghian, Z., Gheidari, D., Safari, F.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume/Issue/Page: 19(9), e0306973
    • Citations: 0
  3. TCAA-promoted novel approach synthesis and in vitro anti-cancer activity evaluation of spiro[indolo[2,1-b]quinazoline-6,4′-pyrano[2,3-c]pyrazole]-5′-carboxamides
    • Authors: Sadeghian, Z., Bayat, M., Eskandari, M., Safari, F.
    • Year: 2024
    • Journal: Results in Chemistry
    • Volume/Page: 9, 101636
    • Citations: 1
  4. The suppression of cell motility through the reduction of FAK activity and expression of cell adhesion proteins by hAMSCs secretome in MDA-MB-231 breast cancer cells
    • Authors: Safari, F., Bararpour, S., Omidi Chomachaei, F.
    • Year: 2024
    • Journal: Investigational New Drugs
    • Volume/Issue/Page: 42(3), pp. 272–280
    • Citations: 1
  5. Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be Phosphorylated
    • Authors: Rasouli, M., Safari, F., Sobhani, N., Alavi, M., Roudi, R.
    • Year: 2024
    • Journal: DNA and Cell Biology
    • Volume/Issue/Page: 43(2), pp. 74–84
    • Citations: 1
  6. IRTKS Elevation in Patients with Colon Cancer and the Curative Influences of Hamsc Secretome on Polarity and Invasion of HT-29 Colon Cancer Cells
    • Authors: Khodabandeh, A., Safari, F., Ebadi Zavieh, S., Mirzanejad, L.
    • Year: 2024
    • Journal: Regenerative Engineering and Translational Medicine
    • Citations: 0
  7. Harnessing Nanotechnology for Idarubicin Delivery in Cancer Therapy: Current Approaches and Future Perspectives
    • Authors: Safari, F., Jalalian, Y., Abdouss, H., Fathi-Karkan, S., Pandey, S.
    • Year: 2024
    • Journal: BioNanoScience
    • Citations: 2
  8. Synthesis, Molecular Docking, and Biological Evaluation of Pyridin-3-yl-Pyrimidin-2-yl-Triazole Derivatives as Anti-cancer Agents
    • Authors: Firoozpour, L., Moghimi, S., Fallah Barzegar, M.H., Safari, F., Foroumadi, A.
    • Year: 2024
    • Journal: Polycyclic Aromatic Compounds
    • Volume/Issue/Page: 44(3), pp. 2062–2076
    • Citations: 1
  9. Synthesis and Biological Evaluation of 12-Aryl-11-hydroxy-5,6-dihydropyrrolo[2″,1″:3′,4′]pyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-8(9H)-one Derivatives as Potential Cytotoxic Agents
    • Authors: Barghi Lish, A., Foroumadi, A., Kolvari, E., Safari, F.
    • Year: 2023
    • Journal: ACS Omega
    • Volume/Issue/Page: 8(45), pp. 42212–42224
    • Citations: 1
  10. Evaluation of SgK269 expression in colon cancer patients and the effects of hAMSCs secretome on tumor invasion through SgK269/c-Src/p-P130Cas/p-Paxillin/p-ERK1/2 signaling pathway in HT-29 colon cancer cells
    • Authors: Safari, F., Ansari Dogaheh, F., Dadashi, H.
    • Year: 2023
    • Journal: 3 Biotech
    • Volume/Issue/Page: 13(11), 346
    • Citations: 1

 

 

Ranal Gurbanov | Cancer Research | Best Researcher Award

Mr. Ranal Gurbanov | Cancer Research | Best Researcher Award

Medical Student at Gazi University School of Medicine, Turkey.

Ranal Gurbanov, an Azerbaijani national born on May 2, 2004, is a promising young individual with a strong academic and humanitarian profile. He earned a bronze medal in the 2019 National Biology Olympiad and participated in the Future Leaders Exchange Program (FLEX) in the U.S., gaining valuable cultural and leadership experiences. Ranal has been recognized for academic excellence by the Baku Department of Education and is actively involved in community service through the “Social and Active Doctors Community (GÜTSAH)” and “KANOPE Blood and Organ Donation Community.” These roles demonstrate his commitment to supporting children with chronic diseases and raising awareness about blood and organ donation. Additionally, Ranal has pursued specialized medical training from prestigious institutions such as the University of Pennsylvania and Acıbadem University. His profile reflects a blend of academic achievement, leadership, and dedication to public health, though he would benefit from further research contributions to strengthen his candidacy for awards.

Profile:

Education

Ranal Gurbanov’s education reflects a strong commitment to academic excellence and personal growth. He began his educational journey with notable achievements at Baku High School No:102, where his exceptional talents earned him an Academic Excellence Award from the Baku Department of Education in 2021. Following this, Ranal participated in the Future Leaders Exchange Program (FLEX), which provided him with an opportunity to study at an American high school and experience a different educational and cultural environment. His commitment to furthering his knowledge is evident in his enrollment in various specialized medical training programs. These include “Vital Signs: Understanding What the Body Is Telling Us” by the University of Pennsylvania, “Clinical Terminology for International and U.S. Students” by the University of Pittsburgh, and several clinical risk management and forensic medicine courses offered by Acıbadem University. This diverse educational background highlights his dedication to both academic and practical learning.

Professional Experience

Ranal Gurbanov has actively engaged in various professional and extracurricular roles that reflect his commitment to both academic excellence and community service. He earned a bronze medal in the 2019 National Biology Olympiad, demonstrating his strong foundational knowledge in biology. His participation in the Future Leaders Exchange Program (FLEX) allowed him to study in the U.S., gaining invaluable cultural and leadership experience. In his volunteer work, Ranal has contributed to the “Social and Active Doctors Community (GÜTSAH),” where he helps improve the lives of children with chronic diseases through moral support and gifts. Additionally, his role in the “KANOPE” Blood and Organ Donation Community showcases his efforts to raise awareness about organ and blood donation, addressing critical healthcare issues in Turkey. His involvement in various medical training programs further highlights his dedication to understanding and improving clinical practices.

Research Interest

Ranal Gurbanov’s research interests are rooted in the intersection of biology, medical ethics, and community health. His early achievements in the National Biology Olympiad reflect a strong foundation in biological sciences, while his academic journey has been enriched by global experiences through the FLEX program, which broadened his understanding of diverse health systems. Ranal’s current focus includes exploring the ethical dimensions of organ donation and transplantation, a field he actively engages in through his role in the “KANOPE Blood and Organ Donation Community.” His interest also extends to clinical risk management and forensic medicine, evidenced by his participation in specialized training programs. Ranal is particularly motivated by addressing public health challenges and improving patient care through innovative approaches. His commitment to community service, coupled with his academic pursuits, underscores a desire to integrate scientific research with practical applications in healthcare.

Research Skills

Ranal Gurbanov has demonstrated a strong foundation in research through his participation in diverse educational and community activities. His involvement in the National Biology Olympiad and subsequent achievements highlight his solid grasp of biological sciences and scientific inquiry. Ranal’s engagement in specialized medical training programs, such as “Vital Signs” and “Clinical Risk Management,” reveals his commitment to understanding complex clinical concepts and research methodologies. Additionally, his role in organizing blood and organ donation awareness campaigns reflects his ability to translate scientific knowledge into public health initiatives. Although his profile is more focused on community service and humanitarian work, these experiences have honed his skills in communication, project management, and ethical considerations in healthcare. To further enhance his research skills, Ranal could benefit from direct involvement in scientific research projects and publications, which would solidify his expertise and contribute to his development as a researcher.

Award and Recognition

Ranal Gurbanov has received notable awards and recognition for his exceptional achievements and contributions. In 2019, he earned a bronze medal at the National Biology Olympiad organized by the Azerbaijan Ministry of Education, highlighting his early excellence in biological sciences. His leadership and adaptability were further recognized when he won the Future Leaders Exchange Program (FLEX) scholarship, allowing him to study in the U.S. and experience diverse cultural values. Additionally, he was honored with the Academic Excellence Award by the Baku Department of Education in 2021 for his outstanding academic performance at Baku High School No:102. Ranal’s commitment to social causes is evident through his active roles in the “Social and Active Doctors Community (GÜTSAH)” and the “KANOPE Blood and Organ Donation Community,” where he has contributed significantly to public health awareness and support for patients with chronic conditions.

Conclusion

Ranal Gurbanov shows tremendous potential and passion, especially in humanitarian and community-driven projects. However, to be a strong candidate for the Best Researcher Award, he needs to enhance his research output and demonstrate more direct contributions to the scientific field through publications or significant research findings. His commitment to learning and social impact is commendable, and with further academic and research development, he could emerge as a future contender.

Publication Top Notes

Ovatodiolide Inhibits Endometrial Cancer Stemness via Reactive Oxygen Species-Mediated DNA Damage and Cell Cycle Arrest

  • Journal: Chemico-Biological Interactions
  • Year: 2024
  • DOI: 10.1016/j.cbi.2024.111244
  • Authors: Chun-Yu Chen, Yu-Zhen Ye, Yu-Hao Huang, Yew-Min Tzeng, Ranal Gurbanov, Wen-Ling Wang, Wen-Wei Chang

 

Mohammed Kashani-Sabet | Oncology | Best Researcher Award

Dr. Mohammed Kashani-Sabet | Oncology | Best Researcher Award

Medical Director, Oncology Service Line, Sutter Health at California Pacific Medical Center Research Institute, United States.

Dr. Mohammed Kashani-Sabet is a distinguished medical professional with extensive expertise in dermatology and oncology. Holding multiple leadership positions, including Medical Director of the Oncology Service Line at Sutter Health and the Cancer Center at California Pacific Medical Center, he has made significant contributions to cancer research and treatment. Dr. Kashani-Sabet received his medical education from renowned institutions such as Harvard University and the State University of New York at Stony Brook. Throughout his career, he has been involved in groundbreaking research focused on melanoma, cutaneous T-cell lymphoma, targeted therapy, and tumor biomarkers. He has received numerous honors and awards for his contributions to the field, including the Clinical Career Development Award from the Dermatology Foundation and the Patients’ Choice Award by Sutter Medical Network. Dr. Kashani-Sabet’s dedication to improving patient care and advancing cancer treatment has earned him widespread recognition and respect in the medical community.

Professional Profiles:

Education:

Dr. Mohammed Kashani-Sabet embarked on his academic journey with a Bachelor’s degree in Biochemical Sciences from Harvard University, followed by a Doctorate in Medicine from the State University of New York at Stony Brook. After completing his medical education, he undertook an internship in Internal Medicine and residency in Dermatology at the State University of New York at Stony Brook and the University of California, San Francisco (UCSF) respectively. Dr. Kashani-Sabet further honed his expertise through a post-doctoral fellowship in Cutaneous Oncology at UCSF’s Department of Dermatology and Division of Hematology/Oncology. This comprehensive educational background laid a robust foundation for his subsequent career as a renowned physician and researcher in the field of dermatology and oncology.

Professional Experience:

Dr. Mohammed Kashani-Sabet has held several prestigious positions throughout his career, demonstrating his leadership and expertise in the field of dermatology and oncology. Currently, he serves as the Medical Director of the Oncology Service Line at Sutter Health and as the Medical Director of the Cancer Center at California Pacific Medical Center. Additionally, he holds the position of Medical Director of the Center for Melanoma Research and Treatment at Sutter West Bay Medical Group, Sutter Pacific Medical Foundation, and California Pacific Medical Center. Dr. Kashani-Sabet also contributes significantly to research as a Senior Scientist at the California Pacific Medical Center Research Institute. His extensive professional experience spans over two decades and encompasses various roles in academia, clinical practice, and administrative leadership within prestigious institutions such as the University of California, San Francisco (UCSF) and the California Pacific Medical Center.

Research Focus:

Dr. Mohammed Kashani-Sabet’s research focus encompasses a broad spectrum of topics within dermatology and oncology, with a particular emphasis on melanoma and cutaneous T-cell lymphoma. His work includes investigating novel targeted therapies, such as ribozymes and siRNAs, for these malignancies. Additionally, he explores tumor metastasis, prognostic modeling, and tumor biomarkers to advance our understanding of these diseases and improve patient outcomes. Dr. Kashani-Sabet’s research efforts aim to translate scientific discoveries into clinical applications, with the ultimate goal of developing more effective treatments and interventions for patients with melanoma and cutaneous T-cell lymphoma.

Research Interest:

Dr. Mohammed Kashani-Sabet possesses a diverse set of research skills honed over years of experience in dermatology and oncology. His expertise includes clinical research, where he designs and conducts studies to evaluate novel therapies for melanoma and cutaneous T-cell lymphoma. In the laboratory, he is skilled in various techniques such as PCR, DNA sequencing, and gene expression analysis, essential for basic and translational research. Dr. Kashani-Sabet also excels in data analysis, utilizing statistical methods and software to interpret clinical and experimental data effectively. With a track record of publishing research findings in peer-reviewed journals, he demonstrates proficiency in scientific writing and manuscript preparation. Additionally, his ability to write grant proposals and collaborate with interdisciplinary teams underscores his commitment to advancing dermatologic oncology research and improving patient care.

Award and Honors:

Dr. Mohammed Kashani-Sabet has been recognized with numerous awards and honors throughout his career, reflecting his exceptional contributions to dermatologic oncology research and patient care. Among these accolades are the Clinical Career Development Award from the Dermatology Foundation in 1997 and the Herschel and Diana Zackheim Endowed Chair in Cutaneous Oncology in the same year. His dedication to teaching and mentorship was acknowledged with the Teacher of the Year Award in 2004, bestowed upon him by the Dermatology Residents at UCSF. Notably, Dr. Kashani-Sabet received the Patients’ Choice Award in 2013 from the Sutter Medical Network for achieving high patient satisfaction scores. His humanitarian efforts were recognized with the Humanitarian Award by the Melanoma Research Foundation in 2014. Moreover, he holds the Chair in Melanoma Research and Treatment at California Pacific Medical Center since 2015, a testament to his leadership and contributions to the field.

Publications:

  1. Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures
    • Authors: Chang, S.H., Ice, R.J., Chen, M., … Soroceanu, L., McAllister, S.D.
    • Citations: 0
    • Year: 2023
  2. Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing
    • Authors: Kashani-Sabet, M., Leachman, S.A., Stein, J.A., … Venna, S., Kirkwood, J.M.
    • Citations: 6
    • Year: 2023
  3. Improving Selection for Sentinel Lymph Node Biopsy among Patients with Melanoma
    • Authors: Miller, J.R., Lo, S.N., Nosrati, M., … Scolyer, R.A., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2023
  4. Erratum: Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
    • Authors: Dar, A.A., Bezrookove, V., Nosrati, M., … McAllister, S., Kashani-Sabet, M.
    • Citations: 0
    • Year: 2023
  5. Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment
    • Authors: Sidorov, M., Dighe, P., Woo, R.W.L., … McAllister, S.D., Soroceanu, L.
    • Citations: 7
    • Year: 2023
  6. Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas
    • Authors: Minor, D.R., Kim, K.B., Karuturi, R.K.M., Kashani-Sabet, M.
    • Citations: 0
    • Year: 2023
  7. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients
    • Authors: Balkin, D.M., Tranah, G.J., Wang, F., … Zager, J.S., Leong, S.P.
    • Citations: 0
    • Year: 2023
  8. BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
    • Authors: Bezrookove, V., Khan, I.A., Nosrati, M., … Dar, A.A., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2022
  9. Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
    • Authors: Chen, M., Jian, D., Sidorov, M., … McAllister, S.D., Desprez, P.-Y.
    • Citations: 2
    • Year: 2022
  10. Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma
    • Authors: Dar, A.A., Bezrookove, V., Nosrati, M., … McAllister, S., Kashani-Sabet, M.
    • Citations: 3
    • Year: 2022